Cargando…
Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
The present study was designed to explore the cross talk between fatty acid synthase (FASN) and HER2 (ErbB2) in ovarian cancer. A total of 60 ovarian cancer patients and 15 normal ovarian tissues were enrolled. Tissue array was conducted by using a tissue microarray instrument. Immunohistochemistry...
Autores principales: | Cai, Yunlang, Wang, Jingmei, Zhang, Lin, Wu, Di, Yu, Dandan, Tian, Xiaoqiang, Liu, Jun, Jiang, Xinru, Shen, Yang, Zhang, Lihua, Ren, Mulan, Huang, Peilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247847/ https://www.ncbi.nlm.nih.gov/pubmed/25433947 http://dx.doi.org/10.1007/s12032-014-0391-z |
Ejemplares similares
-
Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer
por: Wu, Di, et al.
Publicado: (2019) -
Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine
por: Wu, Di, et al.
Publicado: (2015) -
Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
por: DUAN, JIANGMAN, et al.
Publicado: (2016) -
Loss of fatty acid synthase inhibits the “HER2-PI3K/Akt axis” activity and malignant phenotype of Caco-2 cells
por: Li, Nan, et al.
Publicado: (2013) -
Flotillin2 Expression Correlates with HER2 Levels and Poor Prognosis in Gastric Cancer
por: Zhu, Zhi, et al.
Publicado: (2013)